Brief: Circio Announce R&D Collaboration With UTMB
07/01/2026 16:02
Jan 7 (Reuters) - Circio Holding ASA CRNA.OL: UNIVERSITY OF TEXAS MEDICAL BRANCH TO EVALUATE CIRCVEC FOR TREATMENT OF INFECTIOUS DISEASES COLLABORATION BETWEEN CIRCIO AND UTMB TO DESIGN AND TEST CIRCVEC FOR PREVENTION AND TREATMENT OF INFECTIONS, CANCER AND GENE THERAPY CIRCVEC TECHNOLOGY WILL BE UTILIZED FOR LONG-TERM EXPRESSION OF PROTEINS PROTECTING AGAINST DANGEROUS VIRAL PATHOGENS Source text: ID:nMFNcgZVrB Further company coverage: CRNA.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration